Recursion Pharmaceuticals has three different business segments that could grow. Its drug development pipeline will take the longest to yield sales. It'll need to scale up its collaborations and ...

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connect with a previously announced streamlining of the AI biotech’s pipeline.